These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17468954)

  • 1. Disturbance of iron metabolism as a contributing factor to SN hyperechogenicity in Parkinson's disease: implications for idiopathic and monogenetic forms.
    Berg D
    Neurochem Res; 2007 Oct; 32(10):1646-54. PubMed ID: 17468954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
    Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D
    J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker.
    Berg D; Hochstrasser H; Schweitzer KJ; Riess O
    Neurotox Res; 2006 Jan; 9(1):1-13. PubMed ID: 16464747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantia nigra echogenicity is associated with serum ferritin, gender and iron-related genes in Parkinson's disease.
    Li K; Ge YL; Gu CC; Zhang JR; Jin H; Li J; Cheng XY; Yang YP; Wang F; Zhang YC; Chen J; Mao CJ; Liu CF
    Sci Rep; 2020 May; 10(1):8660. PubMed ID: 32457446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.
    Walter U
    Expert Rev Neurother; 2009 Jun; 9(6):835-46. PubMed ID: 19496687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
    Berg D
    J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcranial ultrasound as a risk marker for Parkinson's disease.
    Berg D
    Mov Disord; 2009; 24 Suppl 2():S677-83. PubMed ID: 19877199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Substantia Nigra Hyperechogenicity and Iron Metabolism in the Postural Instability Gait Difficulty Subtype of Parkinson's Disease.
    Ying CC; Wang CS; Ren YK; Ding CW; Zhang YC; Wu J; Yang M; Zhang Y; Mao P; Sheng YJ; Chen XF; Mao CJ; Liu CF
    Ultrasound Med Biol; 2023 Nov; 49(11):2422-2427. PubMed ID: 37666708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease.
    Hochstrasser H; Bauer P; Walter U; Behnke S; Spiegel J; Csoti I; Zeiler B; Bornemann A; Pahnke J; Becker G; Riess O; Berg D
    Neurology; 2004 Nov; 63(10):1912-7. PubMed ID: 15557511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
    Kwon DY; Seo WK; Yoon HK; Park MH; Koh SB; Park KW
    Mov Disord; 2010 Jul; 25(10):1373-8. PubMed ID: 20544813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.
    Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W
    Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra.
    Felletschin B; Bauer P; Walter U; Behnke S; Spiegel J; Csoti I; Sommer U; Zeiler B; Becker G; Riess O; Berg D
    Neurosci Lett; 2003 Nov; 352(1):53-6. PubMed ID: 14615048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease.
    Berg D; Merz B; Reiners K; Naumann M; Becker G
    Mov Disord; 2005 Mar; 20(3):383-5. PubMed ID: 15486999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies.
    Gröger A; Berg D
    J Neural Transm (Vienna); 2012 Dec; 119(12):1523-8. PubMed ID: 22875636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
    Zecca L; Berg D; Arzberger T; Ruprecht P; Rausch WD; Musicco M; Tampellini D; Riederer P; Gerlach M; Becker G
    Mov Disord; 2005 Oct; 20(10):1278-85. PubMed ID: 15986424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound in the (premotor) diagnosis of Parkinson's disease.
    Berg D
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S429-33. PubMed ID: 18267277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial brain sonography findings in clinical subgroups of idiopathic Parkinson's disease.
    Walter U; Dressler D; Wolters A; Wittstock M; Benecke R
    Mov Disord; 2007 Jan; 22(1):48-54. PubMed ID: 17083096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.